Efficacy and safety of repaglinide on glycemic control in diabetic patients with chronic renal failure [Diamond study-2]
Phase of Trial: Phase II
Latest Information Update: 16 May 2016
At a glance
- Drugs Repaglinide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms Diamond study-2
- 30 Apr 2016 Status changed from recruiting to completed.
- 16 Nov 2012 New trial record
- 25 Oct 2012 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.